Longlong Gong

1.5k total citations · 1 hit paper
24 papers, 1.1k citations indexed

About

Longlong Gong is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Longlong Gong has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Longlong Gong's work include Cancer Immunotherapy and Biomarkers (6 papers), Cancer Genomics and Diagnostics (5 papers) and Laser Applications in Dentistry and Medicine (5 papers). Longlong Gong is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Cancer Genomics and Diagnostics (5 papers) and Laser Applications in Dentistry and Medicine (5 papers). Longlong Gong collaborates with scholars based in China, Hong Kong and United States. Longlong Gong's co-authors include Zhengzhi Zou, Yibing Chen, Wei Du, Yucen Song, Haocai Chang, Da Xing, Lei Huang, Shuang Guo, Lei Liu and Qi Shen and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Longlong Gong

22 papers receiving 1.1k citations

Hit Papers

Tumor-associated macrophages: an accomplice in solid tumo... 2019 2026 2021 2023 2019 250 500 750

Peers

Longlong Gong
Longlong Gong
Citations per year, relative to Longlong Gong Longlong Gong (= 1×) peers Magdalena Jarosz–Biej

Countries citing papers authored by Longlong Gong

Since Specialization
Citations

This map shows the geographic impact of Longlong Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longlong Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longlong Gong more than expected).

Fields of papers citing papers by Longlong Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longlong Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longlong Gong. The network helps show where Longlong Gong may publish in the future.

Co-authorship network of co-authors of Longlong Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Longlong Gong. A scholar is included among the top collaborators of Longlong Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longlong Gong. Longlong Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Tao, Qing Zhou, Xuchao Zhang, et al.. (2024). Tumor immune microenvironment of NSCLC with EGFR exon 20 insertions may predict efficacy of first-line ICI-combined regimen. Lung Cancer. 195. 107933–107933. 4 indexed citations
2.
Shi, Mengting, Lanlan Pang, Huaqiang Zhou, et al.. (2024). Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods. Lung Cancer. 192. 107818–107818. 7 indexed citations
3.
Gong, Longlong, Hongbo Zheng, Jiarong Chen, et al.. (2024). Identification of gene variation feature for targeted therapy of non-small cell lung cancer through combined method of DNA and RNA sequencing. Discover Oncology. 15(1). 67–67. 2 indexed citations
4.
Li, Jianxia, Huabin Hu, Ge Qin, et al.. (2023). Biomarkers of Pathologic Complete Response to Neoadjuvant Immunotherapy in Mismatch Repair–Deficient Colorectal Cancer. Clinical Cancer Research. 30(2). 368–378. 16 indexed citations
5.
Wu, Weixin, Liangliang Qiao, Longlong Gong, et al.. (2023). The characteristics and clinical relevance of tumor fusion burden in non-EBV (+) gastric cancer with MSS. BMC Gastroenterology. 23(1). 153–153. 1 indexed citations
6.
Mao, Beibei, et al.. (2022). The characteristics and clinical relevance of tumor fusion burden in head and neck squamous cell carcinoma. Cancer Medicine. 12(1). 852–861. 4 indexed citations
7.
Yang, Yanlong, et al.. (2022). LMO7-ALK Fusion in a Lung Adenocarcinoma Patient With Crizotinib: A Case Report. Frontiers in Oncology. 12. 841493–841493. 3 indexed citations
8.
Li, Liuning, Yang Liu, Longlong Gong, et al.. (2021). Low Infiltration of CD8+ PD-L1+ T Cells and M2 Macrophages Predicts Improved Clinical Outcomes After Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Carcinoma. Frontiers in Oncology. 11. 658690–658690. 21 indexed citations
10.
Peng, Quanzhou, Guanggui Ding, Yefeng Yu, et al.. (2021). Potential Biomarkers and Resistance Mechanisms of Atezolizumab in a Patient with Lung Squamous Cell Carcinoma. Immunotherapy. 14(1). 15–21. 4 indexed citations
11.
Xu, Enwu, Yang Zhou, Yi Zhao, & Longlong Gong. (2021). Impact of clonal hematopoiesis to tumor-targeted liquid biopsy in a Chinese pan-cancer cohort.. Journal of Clinical Oncology. 39(15_suppl). e18700–e18700.
12.
Yan, Linlin, et al.. (2021). Molecular Alterations of Circulating Cell-Free DNA in the Pathological Progression of Hepatocellular Carcinoma. Journal of Oncology. 2021. 1–8. 2 indexed citations
13.
Qiao, Jianghua, Yibing Chen, Yanjun Mi, et al.. (2020). NR5A2 synergizes with NCOA3 to induce breast cancer resistance to BET inhibitor by upregulating NRF2 to attenuate ferroptosis. Biochemical and Biophysical Research Communications. 530(2). 402–409. 28 indexed citations
14.
Gong, Longlong, Xin Jin, Yonghua Li, et al.. (2020). Rosiglitazone ameliorates skeletal muscle insulin resistance by decreasing free fatty acids release from adipocytes. Biochemical and Biophysical Research Communications. 533(4). 1122–1128. 11 indexed citations
15.
Gong, Longlong, et al.. (2020). Photobiomodulation reduces hepatic lipogenesis and enhances insulin sensitivity through activation of CaMKKβ/AMPK signaling pathway. Journal of Photochemistry and Photobiology B Biology. 213. 112075–112075. 21 indexed citations
16.
Gong, Longlong, et al.. (2019). Resveratrol ameliorates metabolic disorders and insulin resistance in high-fat diet-fed mice. Life Sciences. 242. 117212–117212. 79 indexed citations
17.
Gong, Longlong, Zhengzhi Zou, Lei Huang, Shuang Guo, & Da Xing. (2019). Photobiomodulation therapy decreases free fatty acid generation and release in adipocytes to ameliorate insulin resistance in type 2 diabetes. Cellular Signalling. 67. 109491–109491. 31 indexed citations
18.
Chen, Yibing, Yucen Song, Wei Du, et al.. (2019). Tumor-associated macrophages: an accomplice in solid tumor progression. Journal of Biomedical Science. 26(1). 78–78. 802 indexed citations breakdown →
19.
Huang, Lei, Xiaoxiao Jiang, Longlong Gong, & Da Xing. (2015). Photoactivation of Akt1/GSK3β Isoform‐Specific Signaling Axis Promotes Pancreatic β‐Cell Regeneration. Journal of Cellular Biochemistry. 116(8). 1741–1754. 11 indexed citations
20.
Huang, Lei, Longlong Gong, Xiaoxiao Jiang, & Da Xing. (2013). Photoactivation of GLUT4 translocation promotes glucose uptake via PI3-K/Akt2 signaling in 3T3-L1 adipocytes. Journal of Innovative Optical Health Sciences. 7(3). 1350067–1350067. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026